STRATEC Biomedical AG / Key word(s): Miscellaneous
STRATEC converts to registered shares
Birkenfeld, August 25, 2015
STRATEC Biomedical AG, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard, TecDAX) is converting its share capital, currently comprising 11,846,595 shares, after the close of trading on Friday, August 28, 2015, at a ratio of 1:1 from bearer shares with a nominal amount of EUR 1.00 to registered shares in the form of no-par shares (shares without a nominal amount). Shareholdings will be converted by custodian banks and at no charge to shareholders.
This conversion to registered shares, which was approved by the Annual General Meeting on May 22, 2015, is meant to facilitate direct communication with shareholders and increase transparency of the shareholder structure.
All shares in STRATEC Biomedical AG will be listed in the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) as registered shares for the first time on Monday, August 31, 2015. From this point onwards, only the new international and German security identification numbers will be valid, namely ISIN DE000STRA555 (to date DE000728900) and WKN STRA55 (to date 728900). The company's ticker symbol SBS will remain unchanged.
Further information about this conversion to registered shares can be found at www.stratec.com/registered_shares.
Further information can be obtained from:
2015-08-25 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
|Company:||STRATEC Biomedical AG|
|Phone:||+49 (0)7082 7916 0|
|Fax:||+49 (0)7082 7916 999|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart|
|End of News||DGAP News-Service|